Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

A patient with complete hair loss regrew all her hair using tofacitinib.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Tamoxifen caused hair loss in a 52-year-old woman.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Certain transcription factors are key in controlling skin stem cell behavior and could impact future treatments for skin repair and hair loss.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.